Trinity Biotech Plc (TRIB) - News Archive

In an important stride for maternal health, Trinity Biotech has secured regulatory approval from the New York State Department of Health (NYSDOH) to begin its PreClara Preeclampsia Testing Service. Set to launch in the...

Trinity Biotechns Strategic Financial Maneuvers and Manufacturing Transition: Paving the Way for Market LeadershipIn a bold move to enhance operational efficiency and fortify its financial standing, Trinity Biotech plc...

Trinity Biotech plc, a biotechnology company based in Dublin, Ireland, has received timely approval from the World Health Organization (WHO) to initiate offshore manufacturing for its TrinScreen HIV and Uni-Gold HIV dia...

Trinity Biotech plc, a commercial-stage biotechnology firm with a focus on human diagnostics and diabetes management, has announced a significant regain of compliance with Nasdaq listing requirements. On November 6, 202...

Dublin, Oct. 25, 2024 — In a significant move signaling its ambition to broaden its portfolio, Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company renowned for its innovations in human diagnosti...

Continuous Glucose Monitoring: Paving the Path for Enhanced Diabetes Management - A Closer Look at Trinity Biotech’s BreakthroughIn an era where innovative technologies are transforming healthcare, Trinity Biotech plc (...

In a significant move to strengthen its footprint in the maternal health market, Trinity Biotech Plc (NASDAQ: TRIB) has announced the acquisition of Metabolomics Diagnostics, a pioneering company renowned for its deep-t...

Trinity Biotech Sets Its Sights on Indian CGM Market in Partnership with Bayer Expanding Horizons in Diabetes ManagementIn a strategic move poised to redefine diabetes care, Dublin-based Trinity Biotech plc has announce...

DUBLIN, Ireland Trinity Biotech plc (Nasdaq: TRIB), a biotechnology company specializing in human diagnostics and diabetes management, announced significant progress in developing its continuous glucose monitor (CGM) te...

Trinity Biotech Announces Significant Q2 2024 Revenue Growth, UK Distribution Deal, and Plans for Expansion in Asia Dublin, Ireland, January 31, 2024 Trinity Biotech plc (Nasdaq: TRIB) is marking a period of significant...

Trinity Biotech Initiates European Pre-Pivotal Trial for Optimization of CGM SensorTrinity Biotech plc, a leading biotechnology company focused on human diagnostics and diabetes management solutions, has recently taken...

DUBLIN, Ireland, May 16, 2024 - Trinity Biotech plc (Nasdaq: TRIB), a leading commercial-stage biotechnology company specializing in human diagnostics and diabetes management solutions, announced today a monumental stra...

Trinity Biotech Experiences Increased Orders for TrinScreen HIV and Raises 2024 Sales GuidanceDUBLIN, Ireland, May 13, 2024 - Trinity Biotech plc (Nasdaq: TRIB), a biotechnology company specializing in human diagnostics...

Trinity Biotech Regains Nasdaq Compliance Following Minimum Closing Bid Price RuleDUBLIN, Ireland - Trinity Biotech Plc. (NASDAQ: TRIB) announced today that it has successfully regained compliance with the minimum closi...

Trinity Biotech Plc Finalizes ADS Ratio Change, Offering Greater Value to InvestorsDublin, Ireland, Feb. 15, 2024 - Trinity Biotech Plc. (NASDAQ: TRIB), a leading biotechnology company, has announced the finalization of...

Trinity Biotech Plc, a leading healthcare company, has recently announced that its New York-based reference laboratory, Immco Diagnostics, has applied for a Proprietary Laboratory Analyses (PLA) code for its Early Sjogr...

Trinity Biotech Announces Partnership with Bayer for Launch of CGM Biosensor Device in China and IndiaDublin, Ireland - January 31, 2024 - Trinity Biotech plc (Nasdaq: TRIB) has made an exciting revelation today as the...

Trinity Biotech s New Strategy in the Expanding Biosensor MarketTrinity Biotech Plc, a company known for its development, manufacturing, and marketing of diagnostic products for clinical laboratories and point-of-care t...

Dublin-based medical diagnostics enterprise, Trinity Biotech, announced this week that they have commenced the shipping of their groundbreaking HIV screening test, TrinScreen HIV, to Kenya. This news comes as a signific...

Trinity Biotech, a leading global provider of diagnostic solutions, has recently made significant changes to its management team. The company announced that John Gillard has been appointed as the new Chief Executive Off...